My Personal Biomedical Research Feed – Ralph Turchiano, CEO Alchepharma
**Note: the release below is from the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2023, Copenhagen, 15-18 April). Please credit the conference if you use this story** In the highly…
After completing a course of nirmatrelvir-ritonavir, a treatment for at-risk patients who have contracted COVID-19, some patients have reported worsening symptoms and viral rebound. But does viral rebound and…
1. Symptom and viral rebound uncommon after untreated COVID-19 infection Combination of symptom and high-level viral rebound observed in only 3% of persons with COVID-19 Abstract: https://www.acpjournals.org/doi/10.7326/M22-2381 URL goes live when…
ITHACA, N.Y. -- Viral DNA in human genomes, embedded there from ancient infections, serve as antivirals that protect human cells against certain present-day viruses, according to new research. The paper, “Evolution…
Remnants of ancient viruses in the human genome are active in healthy tissues as well as diseased ones, limiting their utility as disease biomarkers, according to a study by Aidan…
RICHLAND, Wash.—The virus that causes COVID-19 undertakes a massive takeover of the body’s fat-processing system, creating cellular storehouses of fat that empower the virus to hijack the body’s molecular machinery…
Polio could soon be wiped out—but only if scientists can track down the last carriers By Helen Branswell Image: GETTY IMAGES Global eradication of polio has been the…
2009 study posted for filing Contact: Michael Woods m_woods@acs.org 202-872-6293 American Chemical Society Scientists in China have discovered that roots of a plant used a century ago during the great…
You must be logged in to post a comment.